-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
-
Summary
-
Atea Pharmaceuticals, Inc. annual and quarterly Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 31 Dec 2018 to 31 Dec 2025.
- Atea Pharmaceuticals, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2025 was $347,000, a 331% decline year-over-year.
- Atea Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2025 was $25,745,000, a 9742% decline from 2024.
- Atea Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $267,000, a 3.9% increase from 2023.
- Atea Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $257,000, a 31% decline from 2022.